Aragen Life Sciences begins operations at high-potency platform in Hyderabad

Aragen Life Sciences has initiated operations at its new high-potency manufacturing platform in Hyderabad. The facility, measuring 15,000 square feet, can produce 500-600 kg of active pharmaceutical ingredients annually. It aims to streamline the transition of highly potent molecules from discovery to commercial supply. The company has invested over Rs 1,000 crore in capital expenditures over three years.